Poging GOUD - Vrij
Novo bets on Emcure in obesity-drug war
Mint Mumbai
|November 11, 2025
Danish drugmaker Novo Nordisk on Monday announced an exclusive partnership with Punebased Emcure Pharmaceuticals to distribute its weightloss therapy semaglutide, as competition in India's fastgrowing anti-obesity drug market heats up.
US drug giant Eli Lilly had announced a similar tie-up last month with Mumbai-headquartered Cipla for its antiobesity drug Tirzepatide.
Novo and Emcure will launch semaglutide under a new brand name, Poviztra, as a 2.4mg weekly injection, they said in a statement. The companies did not yet reveal the pricing plan and launch date, but said they would be "very competitive" in pricing.
Dit verhaal komt uit de November 11, 2025-editie van Mint Mumbai.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Mumbai
Mint Mumbai
No silver bullet
Is silver set to emerge from the shadow of gold as a precious metal? Although its price fell about 2% on Tuesday, it has been enjoying a bull run that makes this dip seem more like a pause for breath than the start of a correction.
1 min
December 03, 2025
Mint Mumbai
Profits, credit lift fundraising by corporates
Corporate fundraising activity saw a significant revival in the September 2025 quarter.
2 mins
December 03, 2025
Mint Mumbai
MAKING SENSE OF IMF RATING AND GDP DATA
India's Q2 growth surpassed expectations, but the IMF rated GDP data quality a 'C'. While India is addressing many of the issues, it's a reminder that the country cannot afford long gaps in statistical improvements.
4 mins
December 03, 2025
Mint Mumbai
Chinese rare-earth dealers are dodging Beijing’s export curbs
Chinese rare-earth magnet companies are finding workarounds to their government's onerous export restrictions, as they seek to keep sales flowing to Western buyers without falling afoul of Chinese authorities.
4 mins
December 03, 2025
Mint Mumbai
Lenskart tops Nykaa on margins
In Lenskart Solutions Ltd's first results post-listing, investor focus should be on the comparison of pro forma financials.
2 mins
December 03, 2025
Mint Mumbai
State-owned banks flag deposit rate woes on policy eve
State-owned lenders have alerted the banking regulator that their inability to cut deposit rates as fast as loan rates is taking a toll on interest margins, three people familiar with the development said.
3 mins
December 03, 2025
Mint Mumbai
India’s battery dreams trip on visa hurdles for Chinese pros
Problems in renewal of visas for Chinese technicians have slowed the pace of buildout of India’s lithium-ion battery manufacturing factories for electric vehicles and energy storage, according to two people aware of the matter.
2 mins
December 03, 2025
Mint Mumbai
All eyes on RBI as fresh fall brings rupee closer to 90
The Indian rupee came within kissing distance of 90 to a dollar on Tuesday before likely central bank intervention rescued it from the brink, but not before it touched a new all-time low.
3 mins
December 03, 2025
Mint Mumbai
Samsung debuts 1st trifold smartphone
Samsung Electronics Co. unveiled its first so-called trifold smartphone, flaunting its engineering prowess in foldable devices even as the broader category has yet to catch on with consumers.
2 mins
December 03, 2025
Mint Mumbai
Meesho under fire from investors over SBI Funds allotment
Meesho Ltd's anchor book faced a setback after several major investors pulled out when the Indian e-commerce firm was said to have allocated about a quarter of the shares in this tranche to SBI Funds Management Pvt,, the country’s largest asset manager, according to people familiar with the matter.
1 mins
December 03, 2025
Listen
Translate
Change font size